Loading...

EBD Group is part of the Knowledge and Networking Division of Informa PLC


This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Informa
NEWS/PRESS RELEASES

BioPharm America™ 2012 program to feature first SciBX: Science-Business eXchange Innovation in BioPharma Summit

This year, EBD Group’s BioPharm America™ will partner with Nature Publishing Group and BioCentury Publications Inc. to host the first SciBX: Science-Business eXchange Innovation in Biopharma Summit. EBD Group, the leading partnering firm for the life science industry, will hold its fifth annual BioPharm America™ event September 19–21, 2012 in Boston, MA, at the Westin Boston Waterfront in collaboration with the Massachusetts Biotechnology Council (MassBio).

“We are pleased to host this prestigious inaugural SciBX Summit at BioPharm America,” said Carola Schropp, President of EBD Group. “We have worked with Nature Publishing Group for many years, and their inclusion in our program will be a highlight of our event this year.”

The EBD Group/SciBX collaboration is unique to the life sciences partnering conference in that it will give delegates privileged access to stakeholders, both from industry and academia, in an area of active innovation in biopharma.

This first SciBX Summit will focus on macrocycles and constrained peptides—challenges and applications. In particular, the Summit will focus the discussion around the opportunities afforded by these compounds in the area of targeting intracellular protein-protein interactions vis-à-vis small molecules and other chemical entities. Their potential for improved oral bioavailability and related benefits will also be discussed.

The summit will consist of a plenary panel discussion featuring stakeholders in the space from biotech, pharma and academia. These panelists will convene as a “think tank” in the run-up to the meeting with the goal of providing the foundation for a Roadmap document capturing the landscape and the challenges, opportunities and necessary next steps in the field that would facilitate its advancement to the next phase of development. This final report will be complemented with insights gained during the Summit taking place at BioPharm America.

“The aim of these Summits, of which the September event at BioPharm America will be the inaugural event, is to capture the interest of all those interested in innovation in the life sciences, and in particular in areas in which there is obvious excitement at the confluence of academia, VCs, biotech and pharma,” said Gaspar Taroncher-Oldenburg, PhD, Managing Editor and Associate Publisher of SciBX. “The focus of this first Summit, macrocycles and constrained peptides, is a perfect example of such a sweet spot in innovation where we expect the frank and in depth discussion within the Think Tank and at the event itself to lead to the formulation of a roadmap of innovation that stakes out the hurdles and goalposts on the path to the next level of development in the area.”

Register for BioPharm America before July 20, 2012 and save USD 200. Registration information for BioPharm America can be found by going towww.ebdgroup.com/bpa/registration/index.php

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group’s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group’s conferences are run with the support of leading corporations and international trade associations and include:

  • BIO-Europe® and BIO-Europe Spring®, Europe’s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
  • BioPharm America™, the fastest growing partnering event in North America
  • Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
  • BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
  • ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
  • EuroMedtech™, EBD Group’s partnering event for the innovative medical technology industry
  • The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.

EBD Group’s sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

About BioPharm America 2014

BioPharm America is where biotech industry partnerships get started. Meet face-to-face with biotech and pharma executives from around the world to identify and enter strategic relationships. Equipped with partneringONE®, BioPharm America is the only event in North America based on the same reputable formula as EBD Group’s acclaimed European events BIO-Europe® and BIO-Europe Spring®.

Additional links and information:

Follow BioPharm America 2014 on Twitter: twitter.com/ebdgroup (hashtag: #BPA14)

Or join the Life Science Partnering group on partnering360® to kick off your partnering activities before BioPharm America, and throughout the year. partnering360 is a dynamic network of life science industry experts that will enable you to continue the dialogue from your partneringONE meetings at events and identify and connect with new partners anytime, year-round. Join the vibrant community of life science companies on partnerning360 today.